Please login to the form below

Not currently logged in
Email:
Password:

Epanutin

This page shows the latest Epanutin news and features for those working in and with pharma, biotech and healthcare.

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer said it "refutes the findings" and will appeal. The allegations centre on Pfizer's sale of its branded product sold as Epanutin to Flynn at that time, which promptly genericised ... Pfizer maintains that its divestment of Epanutin "fully complies

Latest news

  • Pfizer and Flynn accused of overcharging for epilepsy drug Pfizer and Flynn accused of overcharging for epilepsy drug

    Pfizer and Flynn accused of overcharging for epilepsy drug. UK watchdog investigating the firms over the millions of pounds spent on Epanutin. ... Pfizer's brand name for the drug in the UK was Epanutin and according to the CMA the NHS spent around

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics